aTYR PHARMA INC 4
4 · aTYR PHARMA INC · Filed May 8, 2015
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Blackburn Stan
Acting Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2015-05-06+4,085→ 4,085 totalExercise: $14.00Exp: 2025-05-06→ Common Stock (4,085 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on May 6, 2015, such that this option is fully exercisable on May 6, 2019. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
- [F2]Not applicable.